US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist
  • 10.550
  • +0.080+0.76%
Close Apr 18 16:00 ET
  • 10.550
  • 0.0000.00%
Post 16:02 ET
1.68BMarket Cap-7104P/E (TTM)

Neumora Therapeutics Key Stats

Neumora Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.68

-269.57%

Buy

Apr 17, 2024

Neumora Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Neumora Therapeutics Earnings Reports

Analysis

Analyst Rating

Updated: Apr 17, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg